1-4 of 4
Filomena Russo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and Tolerability

Alessandra Tedeschi, Andrea Galitzia, Annamaria Frustaci, Caterina Patti, Alessandro Sanna, Lorena Appio, Luana Schiattone, Paolo Sportoletti, Claudia Barate', Beatrice Casadei, Isacco Ferrarini, Amalia Figuera, Caterina Stelitano, Giacomo Loseto, Andrea Visentin, Marta Coscia, Riccardo Moia, Marina Motta, Filomena Russo, Monica Tani, Enrico Capochiani, Angela Ferrari, Massimo Gentile, Roberta Giacchetti, Annamaria Giordano, Vanessa Innao, Marzia Varettoni, Federico Vozzella, Francesca Cibien, Daniela Gottardi, Enrico Lista, Laura Nocilli, Cristina Pasquini, Anna Vanazzi, Elisa Santambrogio, Roberta Murru, Francesca Romana Mauro, Mariano Lucignano, Luca Laurenti
Journal: Blood
Blood (2023) 142 (Supplement 1): 4646.
https://doi.org/10.1182/blood-2023-186182
Published: 2023
Journal Articles

Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification

Luca Laurenti, Idanna Innocenti, MD, Francesco Autore, MD, Raffaella Pasquale, Barbara Vannata, MD, Stefania Ciolli, Francesca Romana Mauro, MD PhD, Donato Mannina, MD, Giovanni Del Poeta, MD, Giovanni D'Arena, MD, Massimo Massaia, MD, Marta Coscia, MD PhD, Stefano Molica, MD, Gabriele Pozzato, MD, Dimitar G Efremov, MD PhD, Roberto Marasca, MD, Piero Galieni, Antonio Cuneo, MD, Sonia Orlando, Alfonso Piciocchi, BS, Riccardo Boncompagni, Donatella Iolanda Vincelli, MD, Anna Marina Liberati, MD, Filomena Russo, Robin Foa
Journal: Blood
Blood (2016) 128 (22): 3240.
https://doi.org/10.1182/blood.V128.22.3240.3240
Published: 2016
Journal Articles

Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study

Francesca Romana Mauro, MD PhD, Francesco Zaja, Stefano Molica, MD, Marta Coscia, MD PhD, Anna Marina Liberati, Alfonso Piciocchi, Fiorella Ilariucci, MD, Filomena Russo, MD, Francesca Re, MD, Alessandra Tedeschi, MD, Anna Baraldi, MD, Angelo Michele Carella, Alessandro Gozzetti, MD, Giovanni Del Poeta, Pr, MD, Agostino Cortelezzi, MD, Roberta Battistini, MD, Emilia Iannella, MD, Antonietta Ferretti, MD, Ilaria Del Giudice, MD PhD, Irene Della Starza, PhD, Sara Raponi, PhD, Maria Stefania De Propris, PhD, Caterina Ilari, PhD, Luciana Cafforio, PhD, Mauro Nanni, PhD, Paola Fazi, Marco Vignetti, Antonino Neri, Pr, MD, Giorgina Specchia, Pr, MD, Antonio Cuneo, Pr, MD, Anna Guarini, Robin Foà
Journal: Blood
Blood (2015) 126 (23): 2946.
https://doi.org/10.1182/blood.V126.23.2946.2946
Published: 2015
Journal Articles

Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors

Elena Masselli, MD, Prisco Mirandola, PhD, Giuliana Gobbi, PhD, Cecilia Carubbi, MS, Sabrina Bonomini, PhD, Monica Crugnola, MD, Filomena Russo, MD, Luisa Craviotto, MD, Benedetta Cambò, MD, Caterina Plenteda, MD, Elena Rossetti, MD, Cecilia Caramatti, MD, Franco Aversa, MD, Marco Vitale, MD
Journal: Blood
Blood (2013) 122 (21): 114.
https://doi.org/10.1182/blood.V122.21.114.114
Published: 2013